Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SIBN stock hub

SI-BONE, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SIBNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

542.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SIBN

In the news

Latest news · SIBN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-11

P25 -105.6P50 -46.5P75 -3.1

ROIC-6.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SIBN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001459839
Company name	SI-BONE, Inc.
Country	United States
Country code	US
Cusip	825704109
Employees	376
Employees Change	27%
Employees Change Percent	7.74
Enterprise value	$431.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2018-10-17
Isin	US8257041090
Last refreshed	2026-05-10
Market cap	$542.9M
Market cap category	Small-Cap
Price	$12.27
Price currency	USD
Rev Per Employee	534,375x
Sector	Healthcare
Sic	3841
Symbol	SIBN
Website	https://si-bone.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.48%
EV Sales Forward	1.84x
EV/Sales	2.15x
FCF yield	-1.67%
P/B ratio	3.02x
P/S ratio	2.7x
PS Forward	2.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-11.11%
EBITDA Margin	-8.24%
Gross margin	79.57%
Gross Profit	$159.9M
Gross Profit Growth	21.01%
Gross Profit Growth Q	14.84%
Gross Profit Growth3 Y	20.8%
Gross Profit Growth5 Y	19.91%
Net Income	$-18.9M
Net Income Growth Quarters	14%
Net Income Growth Years	3%
Pretax Margin	-9.41%
Profit Margin	-9.41%
Profit Per Employee	$-50,277
ROA	-5.95
Roa5y	-13.53
ROCE	-10.47
ROE	-10.97
Roe5y	-30.32
ROIC	-6.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.78%
Cagr3y	-17.72%
Cagr5y	-17.86%
EPS Growth Quarters	14
EPS Growth Years	3
OCF Growth Q	46.69%
Revenue Growth	20.19x
Revenue Growth Q	14.99x
Revenue Growth Quarters	22x
Revenue Growth Years	9x
Revenue Growth3 Y	23.6x
Revenue Growth5 Y	22.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.86
Assets	$238.6M
Cash	$147.8M
Current Assets	$216.1M
Current Liabilities	$25.3M
Debt	$36.7M
Debt Equity	$0.21
Equity	$177.5M
Interest Coverage	-8.5
Liabilities	$61M
Long Term Assets	$22.4M
Long Term Liabilities	$35.7M
Net Cash	$111.1M
Net Cash By Market Cap	$20.47
Net Cash Growth	-1.27%
Net Debt Equity	$-0.63
Tangible Book Value	$177.5M
Tangible Book Value Per Share	$4.07
WACC	7.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.55
Inventory Turnover	1.35
Net Working Capital	$44M
Quick ratio	7.05
Working Capital	$190.8M
Working Capital Turnover	$1.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.6%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.77%
200-day SMA	15.95
3Y total return	-44.3%
50-day SMA	13.44
50-day SMA vs 200-day SMA	50under200
5Y total return	-62.61%
All Time High	37.21
All Time High Change	-67.02%
All Time High Date	2021-05-04
All Time Low	7.2
All Time Low Change	70.42%
All Time Low Date	2020-03-18
ATR	0.73
Beta	0.67
Beta1y	0.88
Beta2y	0.95
Ch YTD	-37.78
High	12.95
High52	21.89
High52 Date	2026-01-08
High52ch	-43.95%
Low	12.25
Low52	11.8
Low52 Date	2026-04-29
Low52ch	3.98%
Ma50ch	-8.69%
Price vs 200-day SMA	-23.07%
RSI	40.35
RSI Monthly	41.19
RSI Weekly	35.42
Sharpe ratio	-0.61x
Sortino ratio	-0.74
Total Return	-3.6%
Tr YTD	-37.78
Tr1m	-6.83%
Tr1w	-7.12%
Tr3m	-21.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.19
Earnings Revenue Estimate	51,190,784x
Earnings Revenue Estimate Growth	8.23x
Operating Income	$-22.3M
Operating margin	-11.11
Price target	$23.88
Price Target Change	$94.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42,766,064%
Float Percent	96.66%
Shares Insiders	3.34%
Shares Institutions	102.08%
Shares Out	44,243,715
Shares Qo Q	0.74%
Shares Yo Y	3.6%
Short Float	10.83%
Short Ratio	6.49
Short Shares	10.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-34.6M
Average Volume	594,852x
Bv Per Share	4.07
CAPEX	$-8.4M
Ch1m	-6.83
Ch1w	-7.12
Ch1y	-29.77
Ch3m	-21.3
Ch3y	-44.3
Ch5y	-62.61
Ch6m	-22.19
Change	-5.25%
Change From Open	-5.25
Close	12.95
Days Gap	0
Depreciation Amortization	5,770,000
Dollar Volume	8,905,946.4
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$-22.3M
EBITDA	$-16.6M
EPS	$-0.44
F Score	4
FCF	$-9.1M
FCF EV Yield	-2.11x
FCF Per Share	$-0.21
Financing CF	3,376,000
Fiscal Year End	December
Founded	2,008
Investing CF	4,160,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	15.99
Ma150ch	-23.26%
Ma20	13.39
Ma20ch	-8.35%
Net CF	7,292,000
Next Earnings Date	2026-05-11
Open	12.95
Optionable	Yes
Position In Range	2.86
Post Close	12.27
Postmarket Change Percent	1.96
Postmarket Price	$12.51
Ppne	22,385,000
Price Date	2026-05-08
Ptbv Ratio	3.06
Relative Volume	1.22x
Revenue	200,925,000x
SBC By Revenue	12.7x
Share Based Comp	25,524,000
Tr6m	-22.19%
Us State	California
Volume	725,831
Z Score	5.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SIBN pay a dividend?

Capital-return profile for this ticker.

Performance

SIBN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SIBN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+102.1%

Float: +96.7% of shares outstanding

Insider ownership

+3.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SIBN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.4

Neutral momentum band

Price vs 200-day MA

-23.1%

50/200-day relationship not available

Beta (5Y)

0.67

Less volatile than the market

Sharpe ratio

-0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SIBN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SIBN stock rating?

SI-BONE, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SIBN analysis?

The full report lives at /stocks/SIBN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SIBN?

The latest report frames SIBN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SIBN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.